Volume 14 | MTTLR

Articles
Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry	Ariel Katz
Restoring the Genetic Commons: A “Common Sense” Approach to Biotechnology Patents in the Wake of KSR v. Teleflex	Anna Bartow Laakmann
Software Development as an Antitrust Remedy: Lessons from the Enforcement of the Microsoft Communications Protocol Licensing Requirement	William H. Page & Seldon J. Childers
“Justice, and Only Justice, You Shall Pursue”: Network Neutrality, the First Amendment and John Rawls’s Theory of Justice	Amit M. Schejter & Moran Yemini
Comment
The Patent End Game: Evaluating Generic Entry into a Blockbuster Pharmaceutical Market in the Absence of FDA Incentives	Jeremiah Helm
Notes
Copyright and YouTube: Pirate’s Playground or Fair Use Forum?	Kurt Hunt
The FCC Complaint Process and “Increasing Public Unease”: Toward an Apolitical Broadcast Indecency Regime	Kurt Hunt
FDA Approval of Generic Biologics: Finding a Regulatory Pathway	Kathleen R. Kelleher

Articles
The General Public License Version 3.0: Making or Breaking the Foss Movement?	Clark D. Asay
E-Contract Doctrine 2.0: Standard Form Contracting in the Age of Online User Participation	Shmuel I. Becher & Tal Z. Zarsky
Research Tool Patents After Integra v. Merck—Have They Reached a Safe Harbor?	Wolrad Prinz zu Waldeck und Pyrmont
Notes
Synopsis of the Extraterritorial Protection Afforded by Section 337 as Compared to the Patent Act	Neil F. DuChez
A New Frontier or Merely a New Medium? An Analysis of the Ethics of Blawgs	Justin Krypel